In the News

Dr. Scherer awarded Manpei Suzuki Award for Diabetes Research

 

The Manpei Suzuki Diabetes Foundation announced Phillip E. Scherer, Ph.D., as the winner of the 2018 Manpei Suzuki International Prize for Diabetes Research.

 

A single workout can activate neurons that influence metabolism

 

A new study from Dr. Kevin Williams research lab shows neurons in mice that influence metabolism are active for up to two days after a single workout. The research offers new insight into the brain’s potential role in fitness and – in the longer term – may provide a target for developing therapies that improve metabolism.

Dr. Drazner published study on heart failure risk factors

 

“In our study, genetically determined African ancestry was associated with two factors that are connected with an increased risk of heart failure – higher voltage on an electrocardiogram and thickening of the left ventricle,” said senior author Dr. Mark Drazner, Professor of Internal Medicine and Clinical Chief of Cardiology.

Abraham awarded 2019 Gold Humanism Scholar

 

The Arnold P. Gold Foundation is delighted to announce one the 2019 Gold Humanism Scholars at the Harvard Macy Institute Program for Educators is Reeni A. Abraham, M.D. of University of Texas Southwestern Medical School, whose project focuses on “Reflection Rounds Curriculum Quality Improvement Project”

Cytokines predict immunotherapy problems

 

“Almost a decade into the remarkable era of cancer immunotherapy, immune-related adverse events continue to plague patients and puzzle clinicians,” said senior author Dr. David Gerber, Professor of Internal Medicine and Clinical Sciences and Associate Director for Clinical Research in the Harold C. Simmons Comprehensive Cancer Center. “While some of these toxicities, such as rash and thyroid dysfunction, can be easily managed, others such as pulmonary toxicity may result in hospitalization and even ICU-level care. Identifying these cytokines and other biomarkers for the prediction and tracking of autoimmune toxicity could help us customize immunotherapy, tailor monitoring and increase patient safety, and possibly even expand the use of immunotherapy to populations that are currently excluded.”

Measuring blood pressure at home in U.S. patients

 

A new study has established that blood pressure is considered to be high at 130/80 or above when measured at home in U.S. patients.

Dr. Wanpen Vongpatanasin, Professor of Internal Medicine and Director of the Hypertension Fellowship Program at UT Southwestern Medical Center, led the team of hypertension and cardiology researchers. Their findings are in agreement with guidelines issued in 2017 by the American College of Cardiology (ACC) and the American Heart Association (AHA).

Eavesdropping on fat cells may hold solutions for diabetes

 

A study, published in the journal Cell, shows that fat cells communicate with endothelial cells of the blood vessels that course through fat tissue, and potentially with other organs, by secreted packages of information. This communication between cells was demonstrated in a number of new mouse models that researchers created.

Dr. Philipp Scherer, a metabolism expert and Director of the Touchstone Center for Diabetes Research at UT Southwestern, is excited about the new findings because they will allow researchers to test new ideas and re-examine old ones.

Khera named president of ASPC

 

Dr. Amit Khera has been named President of the American Society for Preventive Cardiology (ASPC), a national organization of individuals with a dedicated interest in the prevention of cardiovascular disease.

Gene variations are frequently reclassified

 

Testing laboratories should periodically review their records and alert physicians when scientific knowledge evolves and genes are reclassified says Dr. Theo Ross, professor of Internal Medicine in the division of Hematology/Oncology

Dr. Arteaga awarded $600,000 from Komen organization

 

Dr. Carlos Arteaga, Director of the Harold C. Simmons Comprehensive Cancer Center and Associate Dean of Oncology Programs has been awarded a $600,000 research grant from the Susan G. Komen organization.